Foresight Diagnostics Reports Clinical Performance Data for ctDNA Assay in Early-Stage Lung Cancer
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
Read More
Search Results for: liver disease
Quest Diagnostics Launches Pharmacogenomics Testing Service for Medication Guidance
New offering combines genetic testing with clinical decision support tools to help optimize medication selection and dosing across multiple specialties.
Read More
Mercy BioAnalytics Raises $59 Million Series B to Advance Cancer Detection Platform
The funding will support commercialization of the company’s extracellular vesicle-based liquid biopsy tests, starting with ovarian cancer screening.
Read More
Randox Laboratories to Expand Jefferson County Facility Into Full Production Operation
The global diagnostics manufacturer plans to transform its West Virginia sales and distribution site into a manufacturing hub for next-generation diagnostic products.
Read More
New Nanoparticle System Triples CRISPR Gene-Editing Efficiency
DNA-wrapped lipid nanoparticles show improved cellular uptake and reduced toxicity compared to standard delivery methods used in COVID-19 vaccines.
Read More